
Dynavax Technologies Corporation DVAX
$ 13.45
0.86%
Annual report 2024
added 02-20-2025
Country |
![]() |
IPO year |
2004 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. Ryan Spencer |
Employees in the company |
231 |
Shares |
130 M |
Market Cap[1] |
$ 1.75 B |
EBITDA (LTM) |
$ 147 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.